A detailed history of Metis Global Partners, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Metis Global Partners, LLC holds 54,238 shares of MDT stock, worth $4.43 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
54,238
Previous 53,479 1.42%
Holding current value
$4.43 Million
Previous $4.21 Million 16.01%
% of portfolio
0.15%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.84 - $91.03 $58,321 - $69,091
759 Added 1.42%
54,238 $4.88 Million
Q2 2024

Aug 06, 2024

BUY
$78.71 - $87.02 $38,804 - $42,900
493 Added 0.93%
53,479 $4.21 Million
Q1 2024

May 06, 2024

SELL
$82.84 - $88.09 $35,786 - $38,054
-432 Reduced 0.81%
52,986 $4.62 Million
Q4 2023

Feb 06, 2024

SELL
$69.43 - $83.43 $544,956 - $654,842
-7,849 Reduced 12.81%
53,418 $4.4 Million
Q3 2023

Nov 07, 2023

BUY
$78.22 - $90.4 $597,131 - $690,113
7,634 Added 14.23%
61,267 $4.8 Million
Q2 2023

Aug 07, 2023

SELL
$79.47 - $91.38 $6,993 - $8,041
-88 Reduced 0.16%
53,633 $4.73 Million
Q1 2023

May 08, 2023

BUY
$76.72 - $87.58 $1.32 Million - $1.51 Million
17,213 Added 47.15%
53,721 $4.33 Million
Q4 2022

Feb 07, 2023

BUY
$76.18 - $87.74 $900,219 - $1.04 Million
11,817 Added 47.86%
36,508 $2.84 Million
Q3 2022

Nov 08, 2022

BUY
$80.75 - $95.31 $91,166 - $107,604
1,129 Added 4.79%
24,691 $1.99 Million
Q2 2022

Aug 08, 2022

BUY
$87.4 - $113.09 $202,942 - $262,594
2,322 Added 10.93%
23,562 $2.11 Million
Q1 2022

May 03, 2022

BUY
$100.58 - $112.38 $1.02 Million - $1.14 Million
10,119 Added 90.99%
21,240 $2.36 Million
Q4 2021

Feb 11, 2022

BUY
$99.53 - $127.75 $1.11 Million - $1.42 Million
11,121 New
11,121 $1.15 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.